| 초록 |
Background: It was known that declining intracellular T-lymphocyte concentration of cyclosporine A precedes acute
rejection in kidney transplant recipients. The aim of this study was to elucidate the impact of various statins on
intracellular cyclosporine A concentration in the PBMC (peripheral blood mononuclear cell).
Method: PBMCs were isolated from 30 ml of freshly collected blood which were obtained from healthy 4 volunteers
with informed consent. PBMC were incubated in the media with 0.1 ml of ND96 buffer containing 200 nm of
cyclosporine A in the presence and absence of rosuvastatin (10 μm, 100 μm), simvastatin (10 μm, 100 μm), atorvastatin
(10 μm, 100 μm), fluvastatin (10 μm, 100 μm), pitavastatin (10 μm, 100 μm) for 30 min at 37℃. The radioactivity was
measured by a MicroBeta TriLux 96-well Scintillation/Luminescence detector (PerkinElmer). We also measured intracellular
cyclosporine A concentration in the presence of the statins (100 μm) in the LLC-PK1 overexpressing P-glycoprotein
cells.
Result: The intracellular concentration of cyclosporine A in the control and in the presence of verapamil was
30.5±6.2 fmol/min/2×105 and 55.8±6.4 fmol/min/2×105 (p=0.008) respectively. The intracellular cyclosporine A
concentration with simvastain (10μm, 100 μm) and with atorvastatin (10μm, 100 μm) showed significant higher value,
67.1±6.7 fmol/min/2×105 (p=0.002), 66.2±4.5 fmol/min/2×105 (p=0.001), 45±4.9 fmol/min/2×105 (p=0.03), 57.5±2
fmol/min/2×105 (p=0.002),respectively. But the others were not (p>0.05). It also revealed higher intracellular cyclosporine
A concentrations in the presence of verapamil, atorvastatin and simvastatin, 398.7±1.1 fmol/min/1×104 (p=
0.0002), 108.3±0.6 fmol/min/1×104 (p=0.04), 222±0.8 fmol/min/1×104 (p=0.01), respectively, in the LLC-PK1 cells.
Conclusion: The intracellular cyclosporine A concentration could be affected variously with statins by p-glycoprotein
mediated inhibition. |